RAGMD identifies the population, intervention, outcomes, and type of evidence needed.
2
Find the evidence
RAGMD searches its evidence library and expands to current literature when needed.
3
Determine what matters
Studies are evaluated for relevance, design, directness, quality, precision, and applicability.
4
Look for disagreement
RAGMD identifies credible conflicting evidence and examines why studies differ.
5
Build the synthesis
The answer is generated from the evidence, with claims connected to sources.
6
Show confidence
RAGMD explains how strongly the body of evidence supports the conclusion.
1
Ask a clinical question
RAGMD identifies the population, intervention, outcomes, and type of evidence needed.
2
Find the evidence
RAGMD searches its evidence library and expands to current literature when needed.
3
Determine what matters
Studies are evaluated for relevance, design, directness, quality, precision, and applicability.
4
Look for disagreement
RAGMD identifies credible conflicting evidence and examines why studies differ.
5
Build the synthesis
The answer is generated from the evidence, with claims connected to sources.
6
Show confidence
RAGMD explains how strongly the body of evidence supports the conclusion.
Progressive depth
10 seconds, 1 minute, or 5 minutes
Scan what you need now — drill into studies, comparisons, and sources when you have more time.
10 seconds
Bottom line + Evidence Confidence
The clinical takeaway and how strongly the evidence supports it.
1 minute
Benefits, risks, conflicts, limitations
Structured sections for a quick clinical read.
5 minutes+
Strongest studies, expert perspectives, full sources
Deep comparison, teaching, and source verification when you need more.
Example
See an evidence-weighted answer
Popular
Does testosterone replacement increase cardiovascular risk?
Product demonstration
Bottom line
For appropriately selected hypogonadal men, current higher-quality evidence does not support a blanket increase in major cardiovascular events from testosterone replacement. Risk still depends on indication, formulation, monitoring, and baseline cardiovascular status. [1–3]
Evidence confidence
High
Multiple high-quality studies directly address this question, with generally consistent findings.
Clinical takeaway
Large randomized trials and contemporary syntheses do not consistently show excess major adverse cardiac events in appropriately indicated hypogonadal men on monitored testosterone therapy.
Important conflicting evidence
Older observational cohorts raised cardiovascular concern, but design limitations and treatment-selection bias limit how directly those signals apply to current practice.
What this evidence does not establish
Optimal monitoring thresholds, patient selection in high-risk cardiovascular disease, and long-term outcomes beyond trial follow-up remain active clinical judgment areas.
Strongest evidence
Landmark RCT
Representative pivotal study from the evidence base
Large randomized trials and contemporary syntheses do not consistently show excess major adverse cardiac events in appropriately indicated hypogonadal men on monitored testosterone therapy.
Trust
Every conclusion has a trail.
Inspect the studies behind the answer. RAGMD links research evidence to its published source, including PubMed identifiers when available.